Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Qu Biologics Inc.
About
Qu Biologics develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer.
- 11 - 50
Highlights
Details
- Last Funding Type
- Private Equity（PE）
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2007
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Qu Biologics is developing a platform of new immunotherapeutic treatments. Our Site Specific Immunomodulators (SSIs) aim to activate the body’s immune system to reverse the chronic inflammation underlying many conditions including cancer and immune-related diseases, such as Crohn’s disease. More than 270 patients with advanced cancer and moderate-to-severe immune-related disease have been treated with Qu Biologics’ SSIs through a compassionate use program. The preliminary findings suggest some promising outcomes which support further research in controlled clinical trials. Currently, we are recruiting for a Phase 1/2 clinical trial in Crohn’s disease. More information on this Crohn’s disease research trial can be found at www.qucrohnstrial.com. Qu Biologics’ goal is to develop SSIs to improve the survival and quality of life of millions of people fighting cancer and the quality of life of people living with debilitating immune-related diseases such as Crohn’s disease, ulcerative colitis and rheumatoid arthritis. - See more at: http://www.qubiologics.com/#sthash.tKIA4N2Z.dpuf
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 1, 2019 | Private Equity（PE） | — | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Asian Capital Alliance
|
— | Private Equity（PE） |
